Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Daily News

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Yael L. Maxwell

January 13, 2021

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

Podcast TCTMD Talking Points

Episode 23: LEADERS FREE - Two-Year Clinical and Subgroup Outcomes

June 21, 2017

Presentation TCT 2016

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

Presenter: David W.M. Muller, Jonathan M. Hill, Philip M. Urban

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

News Features

精益求精：创新支架技术值得继续探索

Todd Neale

November 08, 2015

News Features

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

Todd Neale

November 08, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2014

BioFreedom: From Pilot Results to the Leaders-Free Trial

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban

September 15, 2014

Presentation TCT 2014

Is There a Role for Cilostazol with Contemporary DES?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Young-Hoon Jeong

September 14, 2014

Presentation TCT 2014

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Upendra Kaul

September 14, 2014

Presentation TCT 2014

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne

September 14, 2014

Presentation TCT 2014

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Anthony H. Gershlick

September 14, 2014

Presentation TCT 2014

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Renu Virmani

September 14, 2014

Presentation TCT 2014

Mechanical Issues with Current Metallic DES: Strut Fractures, Recoil, Longitudinal Stent Deformation, and More

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, John A. Ormiston

September 14, 2014

Presentation TCT 2014

Update on Neoatherosclerosis: Frequency, Diagnosis, and Treatment

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Soo-Jin Kang

September 14, 2014

Advertisement

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

New Clarity on Patients at High Risk for Bleeding After PCI

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Episode 23: LEADERS FREE - Two-Year Clinical and Subgroup Outcomes

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

精益求精：创新支架技术值得继续探索

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

BioFreedom: From Pilot Results to the Leaders-Free Trial

Is There a Role for Cilostazol with Contemporary DES?

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Mechanical Issues with Current Metallic DES: Strut Fractures, Recoil, Longitudinal Stent Deformation, and More

Update on Neoatherosclerosis: Frequency, Diagnosis, and Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content